Author:
Zhang Mei-Hua,Lee Jae-Seon,Kim Hee-Jung,Jin Dong-Il,Kim Jong-Il,Lee Kong-Joo,Seo Jeong-Sun
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference40 articles.
1. Neckers L, Schulte TW, Mimnaugh E: Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity. Invest New Drugs 17: 361–373, 1999
2. Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP: Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell 89: 239–250, 1997
3. Munster PN, Srethapakdi M, Moasser MM, Rosen N: Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells. Cancer Res 61: 2945–2952, 2001
4. Nimmanapalli R, O'Bryan E, Bhalla K: Geldanamycin and its analogue 17-allylamino-17-demethoxy-geldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res 61: 1799–1804, 2001
5. Asher G, Lotem J, Kama R, Sachs L, Shaul Y: NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 99: 3099–3104, 2002
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献